Ireland· IE-PA-PA22992/022/002
Pomalidomide Grindeks 2 mg hard capsule
A pomalidomide product containing pomalidomide, registered in Ireland by AS Grindeks. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pomalidomide is registered in 17 of 19 countries.
Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Pomalidomide · ATC L04AX06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pomalidomide costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pomalidomide · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$255.48
The record
At a glance
HPRA (Ireland)- Active substance
- Pomalidomide
- Manufacturer
- AS Grindeks
- Country
- Ireland (IE)
- ATC code
- L04AX06
- ATC class
- Pomalidomide
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22992/022/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for pomalidomide.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pomalidomide · interactions on record
277 records
- 64 severe
- 213 moderate
Most severe, free to view
- ErythropoietinB03XA01severe
- Darbepoetin alfaB03XA02severe
- PeginesatideB03XA04severe
- C1-inhibitor, plasma derivedB06AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pomalidomide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMNOVIDBristol-Myers Squibb Pharma EEIG, Dublin
- NetherlandsImnovid 2 mg, harde capsulesBristol-Myers Squibb Pharma EEIG
- SwedenDavunfite 2 mg Kapsel, hårdDay Zero ehf
- SwitzerlandImnovid
- PolandImnovidBristol-Myers Squibb Pharma EEIG
- FinlandImnovidBristol-Myers Squibb Pharma EEIG
- United StatespomalidomideNovadoz Pharmaceuticals LLC
- SpainIMNOVID 2 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Pomalidomid +pharma, Pomalidomid Devatis
- Belgium · Pomalidomide Eg, Pomalidomide Eugia
- Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
- Cyprus · Pomalidomide, Pomalidomide Adalvo
- Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
- Germany · Pomadel, Pomalidomid 123 Acurae Pharma
- Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
- Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
- Spain · Pomalidomida Abdi, Pomalidomida Erawya
- Finland · Pomalidomid Avansor, Pomalidomid Devatis
- France · Pomalidomide Eg, Pomalidomide Eugia
- United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
- Greece · Polidma, Pomalidomide Anabiosis
- Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
- Iceland · Imnovid, Pomalidomide Accord
- Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
- Liechtenstein · Imnovid, Pomalidomide Accord
- Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
- Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
- Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
- Malta · Pomalidomide, Pomalidomide Clonmel
- Netherlands · Polidma, Pomalidomide Adalvo
- Norway · Imnovid, Pomalidomid Devatis
- Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
- Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
- Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
- Sweden · Davunfite, Pomalidomid Avansor
- Slovenia · Pomadel, Pomalidomid Grindeks
- Slovakia · Pomalidomid Grindeks, Pomalidomid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0bed07d-a45e-4b1e-a8de-bb3aea5c685f GET /v1/drugs/e0bed07d-a45e-4b1e-a8de-bb3aea5c685f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AX06"
],
"strength": null,
"pa_number": "PA22992/022/002",
"substances": [
"Pomalidomide"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "01/11/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0162-006-001"
}See everything about pomalidomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.